Lactated Ringers Injection Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, Canada, China, UK, France, Japan, Brazil, India, Mexico - Size and Forecast 2024-2028

What is the Size of Lactated Ringers Injection Market?

The lactated ringers injection market size is forecast to increase by USD 508.5. million, at a CAGR of 5.6% between 2023 and 2028. The market is driven by the prevalence of traumatic hemorrhages and the popularity of intravenous therapy in healthcare settings. Sodium lactate solutions, such as lactated ringers, are commonly used to treat fluid and electrolyte imbalances, particularly in cases of severe blood loss. The use of these injections is on the rise due to their ability to provide essential nutrients and maintain fluid balance without causing fluid overload, as opposed to traditional crystalloid solutions like normal saline. However, regulatory complexities associated with the production and administration of lactated ringers injections pose challenges to market growth. Mannitol, a common osmotic diuretic used in conjunction with lactated ringers, adds to the regulatory complexity due to its potential side effects and interactions with other medications. To ensure patient safety and regulatory compliance, manufacturers and healthcare providers must adhere to strict guidelines for the production, storage, and administration of lactated ringers injections.

Request Free Lactated Ringers Injection Market Sample

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• Type
  • Standard lactated ringers solution
  • Lactated ringers with additives
  • Lactated ringers with dextrose
• Application
  • Hydration and electrolyte replacement
  • Surgical and post-operative care
  • Trauma and emergency care
  • Others
• Geography
  • North America
    • Canada
    • Mexico
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

Which is the Largest Segment Driving Market Growth?

The standard lactated ringers solution segment is estimated to witness significant growth during the forecast period. Lactated Ringer's Solution (LRS), also referred to as Hartmann's solution or ringers lactate, is a widely used intravenous fluid in healthcare settings for fluid resuscitation and electrolyte replacement. The solution's composition includes essential electrolytes like sodium chloride, potassium chloride, calcium chloride, and sodium lactate, which are dissolved in sterile water. The electrolyte profile of LRS closely resembles that of physiological saline, making it isotonic with blood, and having an osmolarity of approximately 273 mOsm/L and a pH of around 6.5.

Get a glance at the market share of various regions Download the PDF Sample

The standard lactated ringers solution segment was valued at USD 638.60 million in 2018. LRS plays a crucial role in managing dehydration in patients who cannot consume fluids orally due to conditions such as surgery, vomiting, or diarrhea. It is also employed to manage hypotension (low blood pressure) and vasoplegia (reduced responsiveness of blood vessels to vasoconstrictors). The solution's balanced electrolyte composition helps maintain the body's fluid and electrolyte balance, which is vital for optimal organ function. In medical emergencies such as cardiac arrest, LRS is administered intravenously to restore fluid and electrolyte balance and improve blood pressure. Potassium chloride, an essential electrolyte in LRS, plays a crucial role in maintaining normal heart function and preventing life-threatening arrhythmias. Overall, LRS is a valuable tool in the medical arsenal for managing various clinical conditions and improving patient outcomes.

Which Region is Leading the Market?

For more insights on the market share of various regions Request Free Sample

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The lactated ringer's injection market in North America is driven by several factors, including the increasing population of older adults and the subsequent rise in healthcare spending. According to the Population Reference Bureau (PRB), the number of Americans aged 65 and above is projected to increase from 57.8 million in 2020 to 82 million by 2050, representing a 47% growth. This demographic shift is attributed to the aging of the baby boomer generation. The elderly population is more prone to chronic conditions and requires frequent medical interventions, including surgeries and post-operative care. Consequently, the demand for lactated ringers injections as an alkalinizing agent during ischaemia-reperfusion injury and trauma patients' treatment is expected to increase. This trend is likely to continue, given the growing number of older adults and their increased healthcare needs.

How do Technavio's company ranking index and market positioning come to your aid?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AdvaCare Pharma - This company offers lactated ringers injection, which is an isotonic solution used for intravenous rehydration therapy, containing sodium chloride, sodium lactate, potassium chloride, and calcium chloride.

Technavio provides the ranking index for the top 15 companies along with insights on the market positioning of:

• Alfa Laboratories S.A.L.
• Baxter International Inc.
• B. Braun of America Inc.
• Becton Dickinson and Co.
• Dechra Pharmaceuticals Plc
• Fresenius Kabi AG
• ICU Medical Inc.
• JoinHub Pharma
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Sigma Aldrich Chemicals Pvt. Ltd.
• Soxa Formulations and Research Pvt. Ltd.
• Vedco Inc.
• Zoetis Inc.

Explore our company rankings and market positioning Request Free Sample

How can Technavio Assist you in Making Critical Decisions?

What is the Market Structure and Year-over-Year growth of the Market?

Market Dynamic

The market is witnessing significant growth due to its extensive usage in various medical applications, particularly in trauma care. This injection is a balanced electrolyte solution that closely mimics the composition of human plasma, making it an essential component in trauma resuscitation protocols. Trauma patients often experience metabolic acidosis, which can be managed effectively with Lactated Ringer's injections. These injections help maintain the acid-base balance in the body and provide essential electrolytes to counteract the effects of vasoplegia and sympatholysis, common complications in trauma patients. Moreover, Lactated Ringer's injections play a crucial role in the treatment of ischaemia-reperfusion injury. This injury occurs when blood flow is restored to an ischaemic tissue, leading to damage due to the production of free radicals. Lactated Ringer's injections help prevent fluid overload, a common complication during the reperfusion phase, by providing adequate fluid replacement without excess electrolytes. Hypovolemia, a condition characterized by insufficient blood volume, is another medical condition where Lactated Ringer's injections are extensively used. These injections help restore blood volume, ensuring adequate tissue perfusion and oxygenation. Furthermore, potassium chloride supplementation is often required in trauma patients, and

Lactated Ringer's injections provide a convenient and effective means of administering this essential mineral. In conclusion, the Lactated Ringer's injection market is experiencing steady growth due to its diverse applications in trauma care. Its ability to manage metabolic acidosis, provide essential electrolytes, and aid in the treatment of ischaemia-reperfusion injury and hypovolemia make it an indispensable tool in the medical field. The ongoing research and development in the field of trauma care are expected to further expand the applications of Lactated Ringer's injections, providing significant opportunities for market growth. The market plays a critical role in managing cardiac arrest in trauma patients, addressing tissue damage in trauma, and supporting metabolic acidosis management. It aids in correcting electrolyte imbalances in trauma, and is essential for mannitol for cerebral edema and sodium lactate infusion therapy. In trauma, it helps combat vasoplegia in trauma, sympatholysis in trauma, and supports treatment of traumatic brain injury and spinal cord injury management. This fluid is also integral to low blood volume resuscitation, preventing fluid overload, and hypovolemia management strategies, with benefits in alkalinizing agents in trauma and calcium chloride administration during ischaemia-reperfusion injury treatment. Additionally, potassium chloride supplementation is critical for maintaining balance.

What are the Primary Factors Driving the Market Growth?

The prevalence of chronic diseases is notably driving market growth. The market experiences substantial growth due to the increasing prevalence of chronic health conditions, such as cancer and hypertension. According to estimates, cancer is the second leading cause of death in the US, with approximately 1.9 million new cases projected in 2023 and 609,820 deaths attributed to this disease. This high incidence and mortality rate underscore the critical need for effective medical interventions and supportive treatments, including lactated ringers solutions, which are essential for fluid resuscitation and electrolyte replacement during cancer treatment.

Lactated ringers injections contribute significantly to managing dehydration and hypovolemia, conditions commonly encountered in patients undergoing cancer therapy. Additionally, these injections possess a metabolic alkalinizing effect, which is beneficial for maintaining proper acid-base balance in the body. The demand for lactated ringers injections healthcare system is expected to remain strong due to their proven efficacy and importance in addressing the complex medical needs of cancer patients. Thus, such factors are driving the growth of the market during the forecast period.

What are the Significant Trends being Witnessed in the Market?

The popularity of intravenous therapy in wellness clinics is the key trend in the market. The market has experienced notable expansion due to the rising utilization of intravenous (IV) therapies in wellness clinics. IV treatments have gained traction in these facilities as a holistic strategy for enhancing hydration, reestablishing electrolyte equilibrium, and promoting general well-being. This trend is particularly noticeable among individuals who seek swift and efficient wellness solutions. The primary reason for the preference of LRS in wellness environments is its capacity to administer fluids and electrolytes directly into the bloodstream. This method guarantees prompt absorption and efficacy, making it an attractive choice for clients requiring rapid hydration or recovery.

This is particularly advantageous for those who are unable to consume orally due to nausea or other gastrointestinal concerns, such as those undergoing traumatic hemorrhage. Sodium lactate and mannitol, the primary components of LRS, contribute to its effectiveness in restoring electrolyte balance and maintaining fluid homeostasis during these situations. The convenience and efficiency of LRS make it an indispensable tool in wellness clinics, ensuring that clients receive optimal care and recovery. Thus, such trends will shape the growth of the market during the forecast period.

What are the Major Market Challenges?

Regulatory complexities associated with lactated ringers injections is the major challenge that affects the growth of the market. The market is governed by a complex regulatory landscape that impacts its production and distribution. As a sterile intravenous solution utilized in various healthcare settings, LRS is subject to stringent regulations enforced by entities such as the US Food and Drug Administration (FDA) and other international regulatory bodies. A significant aspect of this regulatory framework involves the approval process for intravenous solutions. Manufacturers of LRS must submit a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) to regulatory authorities. These applications require extensive data on the formulation's safety, efficacy, and stability.

This data is essential to ensure the solution adheres to the required quality standards for sterility and composition, as any deviations could pose potential risks to patient safety. Ensuring regulatory compliance is crucial for LRS manufacturers, as the solution is an essential electrolyte replacement therapy used to maintain arterial pressure and manage electrolyte imbalances. The solution, primarily composed of sodium chloride and other essential electrolytes, is administered intravenously and plays a vital role in various clinical settings. Hence, the above factors will impede the growth of the market during the forecast period

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Market Analyst Overview

Lactated Ringer's injection is a commonly used intravenous solution in medical settings, particularly for the management of various conditions such as ischaemia-reperfusion, acidosis, dehydration, and hypovolemia. This solution contains sodium lactate, which provides a metabolic alkalinizing effect, helping to maintain mean arterial pressure and electrolyte balance. It is commonly used in trauma patients, including those with traumatic hemorrhage, spinal trauma, and cardiac arrest. The solution also contains sodium chloride, potassium chloride, and calcium chloride to help maintain fluid and electrolyte balance. Lactated Ringer's injection is also used to treat hypotension, vasoplegia, and sympatholysis, and can help prevent fluid overload and tissue attrition. It is important to note that excessive administration of this solution can lead to hypernatremia and hyperchloremic metabolic acidosis. Therefore, careful monitoring of electrolyte levels and mean arterial pressure is essential when administering Lactated Ringer's injection.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies